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Acute chest pain with very elevated troponin level and abnormal EKG in adult population is considered sine qua non to acute
coronary syndrome (ACS) unless proved otherwise. Similar presentation in adolescent population is seen less often but raises
suspicion for ACS. Most common etiology for chest pain with cardiac enzyme elevation in adolescent population is usually viral
myopericarditis. The adolescent population presenting with chest pain and elevated cardiac enzymes should be carefully evaluated
for ACS and other etiologies including myocarditis, myopericarditis, pulmonary embolism, acute rheumatic fever, and trauma.We
report one Japanese adolescent male with mycoplasma pneumoniae myocarditis who presented to the ER with chest pain, elevated
cardiac enzymes, and abnormal EKG.
1. Case
A 17-year-old Japanese origin male presented to the pediatric
ER with sudden onset of sharp substernal chest pain. The
pain started 24 hours prior to admission, described as
nonradiating, sharp, constant pressure over the left chest
with the intensity rating of 10 out of 10. There were no
other associated symptoms like shortness of breath, cough,
diaphoresis, nausea, or vomiting. There was history of one
episode of loose stool and one fever spike of 101 F within
the last 24 hours of admission. Acetaminophen was given at
homewithoutmuch improvement. No significant risk factors
for coronary artery disease were identified. There was no
family history of coronary artery disease or sudden cardiac
death. Patient denied any substance use.
On examination, he was afebrile with heart rate of
74 bpm, respiratory rate of 18/min, BP of 135/50mmhg, and
oxygen saturation of 96−98 percent on room air. Cardiac
examination revealed normal S1S2, no murmur, no rub,
gallop, or distended jugular venous pulse.There was no chest
wall tenderness or hepatomegaly.
Stat EKG and cardiac enzymes were ordered. The initial
EKG (Figure 1) showed sinus tachycardia, ST elevations in
lead II, III, and aVF, and ST depression with T wave inversion
in V1 and V2. Troponin I and CK-MB done on arrival were
markedly elevated (troponin I 17.1 ng/mL, normal < 0.034).
The toxicology screen was negative. A stat echocardiogram
on arrival showed structurally normal heart with normal
origin of coronary arteries, normal left ventricular ejection
fraction without regional wall motion abnormalities, and
no pericardial effusion. However, two echocardiograms that
followed at 8–12-hour intervals showed dilatation of left
atrium and left ventricle with trace mitral regurgitation. Fur-
ther workup including CRP, ESR, nasopharyngeal and throat
viral cultures, EBV DNA, enteroviral culture (rectal), and
serum titers (coxsackie, adenovirus, echovirus, mycoplasma,
and influenza A and B) was sent. Cardiac MRI (Figure 3)
was performed and showed biventricular hypokinesis with
extensive multiple foci of curvilinear and oval shaped con-
trast hyperenhancement involving the central portions of
the anterior, lateral, and inferior wall of LV and posterior
septal and anterior wall of RV with relative sparing of the
endocardial portions of the myocardial walls most suggestive
of myo/myopericarditis.
Initial chest pain subsided within few hours after admis-
sion after giving morphine and sublingual nitroglycerine.
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Figure 1: EKG showing sinus tachycardia, ST elevation in lead II,
III, and aVF, and ST depression with T wave inversion in V1 and V2.
The patient continued to have milder grade, intermittent
chest pain, and low fever which improved over the following
3-4 days of admission. Patient was given course of IVIG
in view of uncertain diagnosis and suspicion of Kawasaki
disease (as patient was having persistent fever and of Japanese
ethnicity). Mycoplasma IgM titers were high (1193 𝜇/mL,
normal < 770). Patient was subsequently treated with course
of azithromycin. Troponin I gradually showed significant
downward trend (0.25 ng/mL on day 6 of admission). The
EKG on second and third days (Figure 2) showed gradual
improvement in ST elevation with low QRS voltages, right-
ward axis, and subsequent normalization of ST elevation
in later EKG’s. The patient remained asymptomatic after
discharge for 10 weeks, till the time of acceptance of this case
report.
2. Discussion
Considering the patient’s young age, no risk factors for
coronary artery disease and other cardiac diseases and no
history of coagulation disorders or substance abuse and
trauma coronary artery disease were less likely. With the
elevated serum titers of mycoplasma and cardiac MRI find-
ings of myocarditis, diagnosis of Mycoplasma pneumoniae
myocarditis was made.
The cardiac origin chest pain represents a very small
proportion (1.5–3 percent) of all pediatric visits to ER for
chest pain [1–3]. Most common cardiac etiologies in healthy
adolescent population includes myopericarditis especially
viral myopericarditis in summermonths and less often bacte-
rial myopericarditis and even less often myocarditis without
apparent pericardial involvement.The cardiac enzymes eleva-
tion can also be seen in cases of myo/myopericarditis [4–6].
Mycoplasma pneumoniae myo/myopericarditis has been
reported in adolescent population [7–17]. There have been
case reports of mycoplasma pneumoniae myo/myopericar-
ditis without associated respiratory symptoms [17]. Myco-
plasma pneumoniae is a common cause of community
acquired pneumonia in young adults. The presence of exan-
thems and gastrointestinal symptoms is also quite common,
but mycoplasma-associated carditis (myo- or pericarditis) is
an uncommon complication especially in pediatric popula-
tion.
Figure 2: EKG showing marked improvement in ST elevation, low
voltage QRS, and rightward axis.
Figure 3: CardiacMRI showingmultiple foci of curvilinear and oval
shaped contrast hyperenhancement involving the central portions of
the anterior, lateral, and inferior wall of LV with relative sparing of
the endocardial portions of the myocardial walls.
These patients can be effectively treated with macrolides
(azithromycin). Tetracyclines and fluoroquinolones may be
considered in older children and adolescents. In our case,
patient was treated with azithromycin course, after diagnosis
was made.
Long-term complications have been reported with
mycoplasma myocarditis. A review by Pönk [7] in 1979
reported 43% of the patients with cardiac sequelae. The
relatively recent review by Paz and Potasman described a
complication rate of less than 30% and attributed it to better
antibiotic coverage [8].
Our case represents uncommon presentation of cardiac
origin chest pain in adolescent population. Although it is
reasonable to consider ACS as first diagnosis in adult patients
and adolescents with risk factors, in other adolescent patients
especially with recent history of febrile illness, infectious
etiology should be considered, as was diagnosed in our
patient. Serial electrocardiogram and cardiac enzymes are
useful diagnostic aid during initial period. The detailed
workup for infectious etiology is important for directed
treatment and future prognosis. Cardiac MRI has emerged
as reliable noninvasive diagnostic study to further support
the diagnosis and if available, should be performed after
stabilization of patient.
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